CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $521,967 | -6.9% | 33,697 | -4.2% | 0.01% | -12.5% |
| Q1 2024 | $560,897 | -11.0% | 35,188 | -6.2% | 0.01% | -33.3% |
| Q4 2023 | $630,409 | -52.7% | 37,502 | -67.1% | 0.01% | -57.1% |
| Q3 2023 | $1,332,730 | -10.2% | 114,006 | +3.2% | 0.03% | -12.5% |
| Q2 2023 | $1,484,771 | -35.8% | 110,474 | -20.8% | 0.03% | -42.9% |
| Q1 2023 | $2,312,098 | +552.7% | 139,451 | +632.2% | 0.06% | +460.0% |
| Q4 2022 | $354,237 | -45.0% | 19,045 | -62.0% | 0.01% | -47.4% |
| Q3 2022 | $644,000 | +563.9% | 50,175 | +53.7% | 0.02% | +533.3% |
| Q3 2020 | $97,000 | -70.0% | 32,653 | -53.3% | 0.00% | -70.0% |
| Q2 2020 | $323,000 | -33.9% | 69,872 | -45.0% | 0.01% | -28.6% |
| Q1 2020 | $489,000 | +256.9% | 126,934 | +247.6% | 0.01% | +366.7% |
| Q4 2019 | $137,000 | -35.1% | 36,514 | -8.3% | 0.00% | -25.0% |
| Q3 2019 | $211,000 | – | 39,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |